Drawing for CERTAL

USPTO serial 79105109

CERTAL

Reviewed by CopyMark Law Group

Reg. 4200573Status 706Registered
Filing date
Status date
Registration date
Sep 4, 2012
Examiner
STRUCK, ROBERT J
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CERTAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC2 North Riverside Plaza, Suite 1500CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products used in industry and science, namely, nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate [and gel ]form and magnetic particles in fluid form, reagents and solvents for sample preparation, [the modification and manipulation of cells,] and for conducting marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis methods for biopolymers, in particular nucleic acids, [proteins,] macromolecules and biologically active substances, and for identifying contamination through biomolecules; namely, reagents for research purposes; kits containing chemicals for sample preparation, [the modification and manipulation of cells,] and for the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, [proteins,] macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material for laboratory or research useACTIVE—
005[Diagnostic preparations for medical purposes; diagnostic preparations for medical and veterinary use, in particular for sample preparation, the modification and manipulation of cells, and for conducting the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, chemical, biochemical and biotechnological preparations, in particular diagnostic reagents and solvents for medical and veterinary use for sample preparation, the modification and manipulation of cells, and for conducting marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis methods for biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits containing medical and veterinary diagnostic preparations, in particular for sample preparation, the modification and manipulation of cells, and for the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material]SECTION 71 - CANCELLED—
009Scientific [ apparatus, instruments and ] equipment, in particular for research and experimentation purposes, [and laboratory apparatus, measuring apparatus and instruments ] in the nature of chromatography columns, [ robots ] [ and preprogrammed smart cards for [ protein, ] DNA and RNA purification protocols, ] [ and for the use of medical and veterinary diagnostic preparations,] in particular for sample preparation, [the modification and manipulation of cells, ] and for the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, [ proteins, ] macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material, all the aforesaid goods included in this classACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Oct 25, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 25, 2023INPCINVALIDATION PROCESSED—
Oct 18, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 19, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 18, 202371AGREGISTERED-SEC.71 ACCEPTED—
Feb 13, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 8, 2022ES71TEAS SECTION 71 RECEIVED—
Sep 4, 2021REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Aug 19, 2021RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 18, 2019INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 26, 2019INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 26, 2019INPCINVALIDATION PROCESSED—
Jun 11, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 11, 2018NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Oct 11, 2018C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 17, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 31, 2018ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 4, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 23, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 10, 2012GPNXNOTIFICATION PROCESSED BY IB—
Dec 5, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 5, 2012FIMPFINAL DISPOSITION PROCESSED—
Dec 4, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 4, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 19, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 19, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 30, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 30, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 30, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 16, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 16, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2012XAECEXAMINER'S AMENDMENT ENTERED—
May 15, 2012ALIEASSIGNED TO LIE—
May 14, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 14, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
May 14, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 12, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 12, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 12, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 16, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 24, 2011RFNTREFUSAL PROCESSED BY IB—
Dec 9, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 7, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 7, 2011RFRRREFUSAL PROCESSED BY MPU—
Dec 7, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 6, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2011DOCKASSIGNED TO EXAMINER—
Dec 5, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 1, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance